AF
KURA icon

Amalgamated Financial’s Kura Oncology KURA Stock Holding History

Amalgamated Financial’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$123K Buy
+7,650
New +$110K ﹤0.01% 2073

Other funds holding KURA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Amalgamated Financial's KURA Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Kura Oncology (KURA) in Q1 2022: 7,650 shares worth $123K. The stake represents ﹤0.01% of the portfolio and ranks #2073 among its holdings.

152 funds tracked by Wall St. Rank hold KURA as of Q1 2022.

  • Amalgamated Financial held 7,650 shares of Kura Oncology worth $123K as of Q1 2022.
  • Kura Oncology was a new Amalgamated Financial position in Q1 2022.
  • Kura Oncology made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2073 holding.
  • 152 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.